Rutger M. Schepp - Concepedia

Author

Rutger M. Schepp

National Institute for Public Health and the Environment ORCID

Also Known As

Rutger M Schepp, Rutger M. Schepp, Rutger Schepp, Rutger M. Schepp

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

National Institute for Public Health and the Environment Amsterdam UMC Location Vrije Universiteit Amsterdam Utrecht University University Medical Center Utrecht Wilhelmina Children's Hospital

About

Rutger M. Schepp is an author at National Institute for Public Health and the Environment specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	343
2	Epidemiology	5	5	185
3	Public Health	3	3	117
4	Allergy	2	2	71
5	Health Sciences	1	1	54

Rutger M. Schepp

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
SARS-CoV-2–Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence Gerco den Hartog, Rutger M. Schepp, Marjan Kuijer, The Journal of Infectious Diseases	2020	163
Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave Eric R. A. Vos, Gerco den Hartog, Rutger M. Schepp, Journal of Epidemiology & Community Health	2020	130
Immunity against Neisseria meningitidis Serogroup C in the Dutch Population before and after Introduction of the Meningococcal C Conjugate Vaccine Richarda M. de Voer, Liesbeth Mollema, Rutger M. Schepp, PLoS ONE	2010	86
Population-based serology reveals risk factors for RSV infection in children younger than 5 years Stijn P. Andeweg, Rutger M. Schepp, Jan van de Kassteele, Scientific Reports	2021	85
Detection of serum antibodies to bovine norovirus in veterinarians and the general population in the Netherlands Marc‐Alain Widdowson, Barry Rockx, Rutger M. Schepp, Journal of Medical Virology	2005	77
Characteristics of HPV-Specific Antibody Responses Induced by Infection and Vaccination: Cross-Reactivity, Neutralizing Activity, Avidity and IgG Subclasses Mirte Scherpenisse, Rutger M. Schepp, Madelief Mollers, PLoS ONE	2013	76
Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: a prospective controlled observational cohort study Marloes W Heijstek, Mirte Scherpenisse, Noortje Groot, Annals of the Rheumatic Diseases	2013	76
Antibody Responses to Respiratory Syncytial Virus: A Cross-Sectional Serosurveillance Study in the Dutch Population Focusing on Infants Younger Than 2 Years Guy A. M. Berbers, Liesbeth Mollema, Fiona van der Klis, The Journal of Infectious Diseases	2020	57
Simultaneous Detection of <i>Haemophilus influenzae</i> Type b Polysaccharide-Specific Antibodies and <i>Neisseria meningitidis</i> Serogroup A, C, Y, and W-135 Polysaccharide-Specific Antibodies in a Fluorescent-Bead-Based Multiplex Immunoassay Richarda M. de Voer, Rutger M. Schepp, F. G. A. Versteegh, Clinical and Vaccine Immunology ImmunohematologyMicrobial PathogensImmunologyImmunodominanceMonoplex Hibps Assay	2009	54
Seroprevalence of seven high-risk HPV types in The Netherlands Mirte Scherpenisse, Madelief Mollers, Rutger M. Schepp, Vaccine Virus EpidemiologyHuman Papillomavirus VaccinesDisease Risk AssessmentVirologyHigh-risk Hpv Types	2012	51

Page 1